Pharmacological preconditioning strategy based on organ specific mechanisms

基于器官特异性机制的药理预处理策略

基本信息

  • 批准号:
    16390453
  • 负责人:
  • 金额:
    $ 9.09万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2006
  • 项目状态:
    已结题

项目摘要

This study was carried out to investigate the mechanisms of pharmacological preconditioning effects against myocardial and renal ischemia-reperfusion injury and to establish the pharmacological therapeutic method for ischemia-reperfusion injury.We investigated the interaction of MCI-154, a calcium sensitizer, and isoflurane on myocardial contractility in chronically instrumented dogs after pharmacological autonomic nervous system activity blockade. MCI-154 increases myocardial contractility and decreases coronary vascular resistance without changing calculated myocardial oxygen consumption during both the conscious state and isoflurane anesthesia. We investigated the hemodynamic and cardioprotective effects of KB-R7943, a Na+/Ca2+ exchanger inhibitor, on myocardial stunning in dogs. KB-R7943 improves myocardial contractile dysfunction after ischemia-reperfusion in a dose-dependent manner, and has no effect on coronary and systemic hemodynamics. We examined protective effects of milrino … More ne in a clinical dose using the myocardial stunning model of anesthetized swine. Milrinone administered before ischemia or just after reperfusion provides protection against ischemia-reperfusion-induced myocardial stunning. We investigated the effects of propofol on myocardial contractility and oxygen balance in acute ischemic myocardium, using coronary microembolization model in dogs. Propofol causes a greater decrease in the contractility of acute ischemic myocardium as compared with normal myocardium, and oxygen imbalance is not involved in the mechanism of this propofol's action. We investigated to determine whether dexmedetomidine has a direct protective effect against hypoxia-reoxygenation-induced left ventricular dysfunction without systemic hemodynamic and humoral effects in isolated rat hearts. Dexmedetomidine exerts the direct protective effect on the left ventricular dysfunction caused by hypoxia-reoxygenation through mainly alpha 2-adrenergic stimulation. We investigated the cardioprotective effects of olprinone, a phosphodiesterase type III inhibitor, on myocardial infarction in rats. The olprinone-induced cardioprotective effect could be exerted via the activation of PI3K-Akt and the inhibition of mPTP during early reperfusion.We investigated pharmacological preconditioning by isoflurane in the rat kidney, isoflurane has a preconditioning effect against renal ischemia/reperfusion injury when administered before ischemia. Inhibition of the protein kinases, JNK and ERK, might be involved in the mechanisms of isoflurane preconditioning. Less
为探讨药物预处理对心肌和肾脏缺血-再灌注损伤的作用机制,建立缺血-再灌注损伤的药物治疗方法,本研究采用慢性机械负荷犬,观察了MCI-154和异氟醚对药物阻断自主神经活性后心肌收缩力的相互作用。MCI-154在清醒状态和异氟烷麻醉期间增加心肌收缩力并降低冠状血管阻力,而不改变计算的心肌耗氧量。我们研究了Na+/Ca 2+交换抑制剂KB-R7943对犬心肌顿抑的血流动力学和心脏保护作用。KB-R7943以剂量依赖性方式改善缺血再灌注后心肌收缩功能障碍,对冠状动脉和全身血流动力学无影响。我们检查了米里诺的保护作用, ...更多信息 临床剂量的NE使用麻醉猪的心肌顿抑模型。在缺血前或再灌注后立即给予米力农可保护缺血-再灌注诱导的心肌顿抑。采用犬冠状动脉微栓塞模型,观察异丙酚对急性缺血心肌收缩力和氧平衡的影响。与正常心肌相比,丙泊酚可使急性缺血心肌的收缩力显著降低,氧失衡与丙泊酚的作用机制无关。我们研究了右美托咪定是否对缺氧-复氧诱导的左心室功能障碍具有直接保护作用,而无全身血流动力学和体液效应。右美托咪定主要通过α 2-肾上腺素能刺激对缺氧复氧所致的左心室功能障碍发挥直接保护作用。我们研究了磷酸二酯酶III型抑制剂奥普力农对大鼠心肌梗死的保护作用。本实验通过对大鼠肾脏缺血/再灌注损伤的药理学预处理研究发现,异氟醚预处理对大鼠肾脏缺血/再灌注损伤具有保护作用,其机制可能与其激活PI 3 K-Akt和抑制mPTP有关。JNK和ERK蛋白激酶的抑制可能参与了异氟醚预处理的机制。少

项目成果

期刊论文数量(54)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
irect protective effects of dexmedetomidine against myocardial ischemia-eperfusioninjury in anesthetized pigs
右美托咪定对麻醉猪心肌缺血再灌注损伤的直接保护作用
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tosaka S;Cho S;Hara T;Tmiyasu S. Sumikawa K;大山 力;Guo Huan;Wang L;Osamu Yoshitomi;Hagisawa S;Tadasuke Use;Hideo Hashiguchi;大山 力;Shunji Takahashi;Ohyama C;Wang L;Osamu Yoshitomi
  • 通讯作者:
    Osamu Yoshitomi
The interaction of MCI' 154, a calcium sensitizer, and isoflurane on systemic and coronary hemodynamics in chronically instrumented dogs.
MCI 154(一种钙敏化剂)和异氟烷对长期接受仪器治疗的狗的全身和冠状动脉血流动力学的相互作用。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Takahashi S;Cho S;Hera P;Ureshino H;Thmiyasu S;Sumilcawa K
  • 通讯作者:
    Sumilcawa K
Role of p38 MAPK in the Cardioprotective Effect of Milrinone Against Myocardial Stunning in Swine.
p38 MAPK 在米力农抗猪心肌顿抑的心脏保护作用中的作用。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yoshitomi O;Hera T;Shibata I;Cho S;Sumilcawa K
  • 通讯作者:
    Sumilcawa K
Cardioprotective effects of colforsin daropate hydrochloride on stunned myocardium in pigs
盐酸考福新达罗帕特对猪心肌顿抑的保护作用
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Miyoshi H;Ureshino H;Cho S;Sumikawa K;Tetsuya Hara;Tadasuke Use;Itsuko Shibata;Shinya Tosaka;Osamu Yoshitomi
  • 通讯作者:
    Osamu Yoshitomi
Catdioprotective effects of KB-R7943,a novel inhihitor of Na+/Ca2+exchanger,on stunned myocardium in anesthetized dogs
新型Na/Ca2交换抑制剂KB-R7943对麻醉犬心肌顿抑的保护作用
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Shibata T;Sumikawa K;他3名;Osamu Yoshitomi
  • 通讯作者:
    Osamu Yoshitomi
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUMIKAWA Koji其他文献

SUMIKAWA Koji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUMIKAWA Koji', 18)}}的其他基金

Conquest of myocardial ischemia reperfusion injury-Control of RISK pathway and antioxidant mechanism-
攻克心肌缺血再灌注损伤-RISK通路调控与抗氧化机制-
  • 批准号:
    19390406
  • 财政年份:
    2007
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Pharmacological control of myocardial contractile function on myocardial stunning
心肌收缩功能对心肌顿抑的药理学控制
  • 批准号:
    13470322
  • 财政年份:
    2001
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Hemodynamic analysis and efficient control of ischemic heart in chronically instrumented dogs
长期使用仪器的狗的血流动力学分析和缺血性心脏的有效控制
  • 批准号:
    10470319
  • 财政年份:
    1998
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Hemodynamic Interactions of Anesthetics and K Channel Openers in Chronically Instrumented Dogs
长期接受仪器治疗的狗中麻醉药和 K 通道开放剂的血流动力学相互作用
  • 批准号:
    07457359
  • 财政年份:
    1995
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Role of microRNA-98 in Myocardial Ischemia Reperfusion Injury in Late Pregnancy
microRNA-98在妊娠晚期心肌缺血再灌注损伤中的作用
  • 批准号:
    10606041
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
Role of the mitochondrial LonP1 in myocardial ischemia and reperfusion injury protection
线粒体LonP1在心肌缺血再灌注损伤保护中的作用
  • 批准号:
    10446477
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
Role of the mitochondrial LonP1 in myocardial ischemia and reperfusion injury protection
线粒体LonP1在心肌缺血再灌注损伤保护中的作用
  • 批准号:
    10640920
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
Developing a new drug for treating myocardial ischemia/reperfusion injury
开发治疗心肌缺血/再灌注损伤的新药
  • 批准号:
    10491205
  • 财政年份:
    2021
  • 资助金额:
    $ 9.09万
  • 项目类别:
Developing a new drug for treating myocardial ischemia/reperfusion injury
开发治疗心肌缺血/再灌注损伤的新药
  • 批准号:
    10325868
  • 财政年份:
    2021
  • 资助金额:
    $ 9.09万
  • 项目类别:
Mitochondrial regulation of the NLRP3 inflammasome in myocardial ischemia-reperfusion injury and heart transplantation
NLRP3炎症小体在心肌缺血再灌注损伤和心脏移植中的线粒体调控
  • 批准号:
    10306406
  • 财政年份:
    2020
  • 资助金额:
    $ 9.09万
  • 项目类别:
Mitochondrial regulation of the NLRP3 inflammasome in myocardial ischemia-reperfusion injury and heart transplantation
NLRP3炎症小体在心肌缺血再灌注损伤和心脏移植中的线粒体调控
  • 批准号:
    10133482
  • 财政年份:
    2020
  • 资助金额:
    $ 9.09万
  • 项目类别:
Are Endothelial Cell and Granulocyte Protein Arginine Deiminase 4 on the Pathway of Inflammasome-Activation, Advancing Myocardial Ischemia Reperfusion Injury?
内皮细胞和粒细胞蛋白精氨酸脱亚胺酶 4 是否在炎症小体激活途径中,促进心肌缺血再灌注损伤?
  • 批准号:
    440378203
  • 财政年份:
    2020
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Research Fellowships
The role of Toll-like receptor 9 in myocardial ischemia/reperfusion injury
Toll样受体9在心肌缺血/再灌注损伤中的作用
  • 批准号:
    19K23968
  • 财政年份:
    2019
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Effects of near infrared radiation and volatile anesthetics on myocardial ischemia and reperfusion injury in hypergrycemia
近红外辐射和挥发性麻醉药对高血糖心肌缺血再灌注损伤的影响
  • 批准号:
    19K09352
  • 财政年份:
    2019
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了